|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03681 SINOMAB BIO-B
Nominal 
1.080 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 2,026 | 48.425% | 1,365 | 0 | 25,913 | 0 |
| Cost of Sales | (1,483) | 57.264% | (943) | -- | -- | -- |
| Gross Profit | 543 | 28.673% | 422 | -- | -- | -- |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (5,396) | (4,289) | (747) | |
| Profit / (Loss) before Taxation | (90,622) | -32.420% | (243,111) | (284,158) | (288,194) | (122,600) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (90,622) | -32.420% | (243,111) | (284,158) | (288,194) | (122,600) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 3,287 | 2.655% | 408 | (4,620) | (10,910) | (14,930) |
| Depreciation & Amortisation | -- | -- | 36,064 | 28,033 | 20,655 | 10,673 |
| Directors' Emoluments | -- | -- | 6,238 | 6,278 | 69,907 | 6,880 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -8.000 | -38.462% | -24.000 | -29.000 | -29.000 | -12.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.131) | (0.303) | (0.148) | (0.140) |
| NBV per share ($) | 0.254 | -- | 0.286 | 0.492 | 0.676 | 0.981 |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -90,622,000 |
| %Change | -32.420% |
| EPS / (LPS) | RMB -0.080 |
| NBV Per Share (¥) | RMB 0.254 |